Partnership Across the Pond: EMA, FDA Foster a Culture of Convergence

BIO 2010: FDA’s Midthun, Throckmorton on Increasing, and Integrating, the Agency’s Expertise

Report from BIO 2010: Does Every Region Really Win in the Biotech Game?

Notes from BIO 2009: On Genentech's Bio-QbD Pilot and Impending "A-MAb" Case Study

Notes from BIO 2009: Up to $400,000/Day to Support an Inspection, Genentech Says

Notes from BIO 2009: Irish Pharma--Can Innovation and Quality Trump Cost and Infrastructure Considerations?

FDA's Most Wanted (or, the Rogues Gallery of Biotech)

A Biotech Bailout, in Some Form, Makes Sense

Engineers Nail QbD in Philadelphia